AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 51-75/115
DIAGNOSIS AND TREATMENT OF TOXOPLASMOSIS OF THE CNS IN PATIENTS WITH AIDS
Authors: KATLAMA C
Citation: C. Katlama, DIAGNOSIS AND TREATMENT OF TOXOPLASMOSIS OF THE CNS IN PATIENTS WITH AIDS, CNS DRUGS, 5(5), 1996, pp. 331-343
SERUM INTERLEUKIN-10 IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME LYMPHOMA PATIENTS
Authors: EDELMAN L DEVEAU C RAPHAEL M MONCHATRE E GABARRE J DEVILLECHABROL A PIALOUX G EMILIE D JOAB I GALANAUD P ROUZIOUX C BARY M BURGARD M GALLAIS H MARS ME GALLAIS J DELLAMONICA P PERBOST I CARLES M CASSUTO JP REBOULOT B QUARANTA M LEFRERE JJ LERABLE J JOUBERT L DUPONT B BEUZELIN C FOURNIER S DORMONT J DELFRAISSY JF LEVY A BOUE F VITTECOQ D BOLLIOT C PECHALAT MT LEBRAS P GOUJARD C QUERTAINMONT Y GASTAUT JA DHIVER C DROGOUL MP GAZENGEL C PERTUISSET N ROTSCHILD M HERSON S COUTELLIER A SERENI D GOMEZ V BACHMEYER C VILDE JL LEPORT C COLASSANTE U PEYNET J LAUX C KATLAMA C BRUCKER G LAURIAN Y KEBEDJI L LAMBERT T SOBEL A DUVAL J MAJERHOLE C DEFORGES L KAZATCHKINE M VELLAY A BUISSON M SULTAN Y GAUTREAU C PICARD F GUILLEVIN L LAROUSSE B TROGOFF B
Citation: L. Edelman et al., SERUM INTERLEUKIN-10 IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME LYMPHOMA PATIENTS, European cytokine network, 7(4), 1996, pp. 785-791
THE USE OF AUXILIARY EVENTS TO IMPROVE THE ANALYSIS OF SURVIVAL FOR HIV-INFECTED PATIENTS - APPLICATION TO THE FRENCH PROSPECTIVE MULTICENTER COHORT (SEROCO)
Authors: FLANDRE P BOUFASSA F GERARD L CARRE N PERSOZ A MEYER L ROUZIOUX C BARY M BURGARD M DELLAMONICA P DURANT J GALLAIS H MARS ME GALLAIS J DORMONT J DELFRAISSY JF LEVY A BOUE F LEFRERE JJ LERABLE J JOUBERT L CASSUTO JP REBOULOT B QUARANTA M DUPONT B BEUZELIN C FOURNIER S VITTECOQ D BOLLIOT C PECHALAT MT HERSON S COUTELLIER A GASTAUT JA DHIVER C DROGOUL MP SERENI D GOMEZ V BACHMEYER C VILDE JL LEPORT C COLASSANTE U KATLAMA C BRUCKER G SOBEL A DUVAL J MAJERHOLD C DEFORGES L KAZATCHKINE M VELLAY A BUISSON M LEBRAS P GOUJARD C QUERTAINMONT Y ANDRIEU JM EVEN P GUILLEVIN L JAROUSSE B TROGOFF B
Citation: P. Flandre et al., THE USE OF AUXILIARY EVENTS TO IMPROVE THE ANALYSIS OF SURVIVAL FOR HIV-INFECTED PATIENTS - APPLICATION TO THE FRENCH PROSPECTIVE MULTICENTER COHORT (SEROCO), Journal of acquired immune deficiency syndromes and human retrovirology, 12(2), 1996, pp. 174-181
A LIFE-THREATENING ADVERSE REACTION DURING TRIMETHOPRIM-SULFAMETHOXAZOLE DESENSITIZATION IN A PREVIOUSLY HYPERSENSITIVE PATIENT INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: CAUMES E GUERMONPREZ G WINTER C KATLAMA C BRICAIRE F
Citation: E. Caumes et al., A LIFE-THREATENING ADVERSE REACTION DURING TRIMETHOPRIM-SULFAMETHOXAZOLE DESENSITIZATION IN A PREVIOUSLY HYPERSENSITIVE PATIENT INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 23(6), 1996, pp. 1313-1314
PYRIMETHAMINE-CLINDAMYCIN VS PYRIMETHAMINE-SULFADIAZINE AS ACUTE AND LONG-TERM THERAPY FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS
Authors: KATLAMA C DEWIT S ODOHERTY E VANGLABEKE M CLUMECK N PAYEN MC MATHIESEN L NIELSEN JO PEDERSEN C DUPONT B PIALOUX G JANBON F REYNES J GALLAIS H MARS ME JEANTILS V SCHNEIDER MC AVEROUS V DECAZES JM DOCOLECOMPTE T MODAI J MOLINA JM BLANC A DELFRAISSY JF GUILLEVIN L JARROUSSE B SEHOUANE R TROGOFF B ARMENGAUD M MARCHOU B MEURISSE JJ GENTILINI M GUICHARD A ROGEAUX O LIVROZET JM TOURAINE JL SERENI D ROUSSEAU F PESCE A COULAUD JP DETRUCHIS P FEGUEUX S MASLO C MATHERON S RAFFI F BASSETTI D CANESSA A DELBONO V DELEO P TERRAGNA A ANTINORI A DAMIANO F ORTONA L PALLAVICINI F TAMBURRINI E ANGARANO G CARBONARA S PASTORE G PORTEGIES P REISS P COSTA J MACHADO J MALTEZ F MORGADO A PROENCA R ANTUNES F CARVALHO C DOROANA M DUARTE N ARAUJO C CHAMPALIMAUD JL COSTA J MANSINHO K SEIXAS J LACRUZ J LOPEZALDEGUER J GATELL JM GUELAR A MALLOLAS J MIRO JM ZAMORA L CLOTET B JOU A RAVENTOS A ROMEU J SIRERA G BOLAO F CASANOVA A GUDIOL F PODZAMCZER D GAZAPO E GONZALEZLAHOZ JM BLANCO LM MORENO V POLO R MARTINEZ MC SANZ J VERDEJO J COSIN J MIRALLES P MORENO S PEREZTASCON O HIRSCHEL B PERRIER A RASSAERT C SOMMEREIJNS B UBRICH V BERLUREAU P DORMONT J LEVY JP MEUNIER F MIGNOLET F VANGLABEKE M VANPOTTELSBERGE C
Citation: C. Katlama et al., PYRIMETHAMINE-CLINDAMYCIN VS PYRIMETHAMINE-SULFADIAZINE AS ACUTE AND LONG-TERM THERAPY FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS, Clinical infectious diseases, 22(2), 1996, pp. 268-275
TUBERCULOSIS AMONG EUROPEAN PATIENTS WITH THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME
Authors: SUDRE P HIRSCHEL BJ GATELL JM SCHWANDER S VELLA S KATLAMA C LEDERGERBER B MONFORTE AD GOEBEL FD PEHRSON PO PEDERSEN C LUNDGREN JD
Citation: P. Sudre et al., TUBERCULOSIS AMONG EUROPEAN PATIENTS WITH THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME, Tubercle and lung disease, 77(4), 1996, pp. 322-328
RISK-FACTORS FOR CEREBRAL TOXOPLASMOSIS I N PATIENTS WITH HIV-INFECTIONS - DEFINITION OF INDICATIONS FOR PRIMARY PROPHYLAXIS - PRPOSALS OF THE PE-TOXOPLASMOSE-ET-AUTRES-INFECTIONS-A-PROTOZOAIRE
Authors: LEPORT C AMBROISETHOMAS P BAZIN C CHENE G DEROUIN F KATLAMA C MAYAUD C PELLOUX H RAFFI F VILDE JL
Citation: C. Leport et al., RISK-FACTORS FOR CEREBRAL TOXOPLASMOSIS I N PATIENTS WITH HIV-INFECTIONS - DEFINITION OF INDICATIONS FOR PRIMARY PROPHYLAXIS - PRPOSALS OF THE PE-TOXOPLASMOSE-ET-AUTRES-INFECTIONS-A-PROTOZOAIRE, La Presse medicale, 25(11), 1996, pp. 519-520
PROPHYLAXIS FOR OPPORTUNISTIC INFECTIONS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: KATLAMA C JOUAN M
Citation: C. Katlama et M. Jouan, PROPHYLAXIS FOR OPPORTUNISTIC INFECTIONS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Medecine et maladies infectieuses, 26(8-9), 1996, pp. 742-751
EPIDEMIOLOGY OF AIDS-RELATED KAPOSIS-SARCOMA IN EUROPE OVER 10 YEARS
Authors: HERMANS P LUNDGREN J SOMMEREIJNS B PEDERSEN C VELLA S KATLAMA C LUTHY R PINCHING AJ GERSTOFT J PEHRSON P CLUMECK N
Citation: P. Hermans et al., EPIDEMIOLOGY OF AIDS-RELATED KAPOSIS-SARCOMA IN EUROPE OVER 10 YEARS, AIDS, 10(8), 1996, pp. 911-917
CLINICAL AND SURVIVAL BENEFIT OF 3TC(TM) IN COMBINATION WITH ZIDOVUDINE-CONTAINING REGIMENS IN HIV-1 INFECTION - INTERIM RESULTS OF THE CAESAR STUDY
Authors: KATLAMA C
Citation: C. Katlama, CLINICAL AND SURVIVAL BENEFIT OF 3TC(TM) IN COMBINATION WITH ZIDOVUDINE-CONTAINING REGIMENS IN HIV-1 INFECTION - INTERIM RESULTS OF THE CAESAR STUDY, AIDS, 10, 1996, pp. 21-21
MULTIPLE OPPORTUNISTIC INFECTIONS PROPHYLAXIS
Authors: KATLAMA C
Citation: C. Katlama, MULTIPLE OPPORTUNISTIC INFECTIONS PROPHYLAXIS, AIDS, 10, 1996, pp. 53-53
REDUCTIONS IN HIV-1 DISEASE PROGRESSION FOR AZT 3TC RELATIVE TO CONTROL TREATMENTS - A METAANALYSIS/
Authors: STASZEWSKI S BARTLETT J ERON J KATLAMA C JOHNSON J HILL AM
Citation: S. Staszewski et al., REDUCTIONS IN HIV-1 DISEASE PROGRESSION FOR AZT 3TC RELATIVE TO CONTROL TREATMENTS - A METAANALYSIS/, AIDS, 10, 1996, pp. 75-75
ATOVAQUONE AS LONG-TERM SUPPRESSIVE THERAPY FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS AND MULTIPLE-DRUG INTOLERANCE
Authors: KATLAMA C MOUTHON B GOURDON D LAPIERRE D ROUSSEAU F ALLEGRE T DROBACHEFF C MONLUN E MALAMUD P SALLES B ROGEZ JF GRANETBRUNELLO P COTTE L CHAUMENTIN G LECLERC V TOLLINCHI F MOREAU J DHIVER C DURAND JM XERIDAT B RAVAUX I REYNES J WINTER C RABAUD C RAFFI F FUZIBERT JG VINTI H GOUGEARD C PERICHON I GILQUIN J CHAPUIS L JEANTILS V GREGOIRE V CHAPUT S DETRUCHIS P PICARD O CROS H BORSALEBAS F LAFEUILLADE A AVEROUS S BOUREZ JM PRAZUCK T
Citation: C. Katlama et al., ATOVAQUONE AS LONG-TERM SUPPRESSIVE THERAPY FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS AND MULTIPLE-DRUG INTOLERANCE, AIDS, 10(10), 1996, pp. 1107-1112
HIGH-RISK OF HIV DISEASE PROGRESSION AFTER INFECTION THROUGH A SEXUALPARTNER WITH AIDS
Authors: CARRE N MEYER L BOUFASSA F DEVEAU C PERSOZ A ROUZIOUX C VILDE JL BARY M BURGARD M DELLAMONICA P DURANT J GALLAIS H MARS ME GALLAIS J DORMONT J DELFRAISSY JF LEVY A BOUE F BECLERE A LEFRERE JJ LERABLE J JOUBERT L CASSUTO JP REBOULOT B QUARANTA M DUPONT B BEUZELIN C FOURNIER S VITTECOQ D BOLLIOT C PECHALAT MT HERSON S COUTELLIER A GASTAUT JA DHIVER C DROGOUL MP SERENI D GOMEZ V BACHMEYER C LEPORT C COLASSANTE U KATLAMA C BRUCKER G SOBEL A DUVAL J MAJERHOLC C DEFORGES L KAZATCHKINE M VELLAY A BUISSON M LEBRAS P GOUJARD C QUERTAINMONT Y ANDRIEU JM EVEN P GUILLEVIN L JAROUSSE J TROGOFF B
Citation: N. Carre et al., HIGH-RISK OF HIV DISEASE PROGRESSION AFTER INFECTION THROUGH A SEXUALPARTNER WITH AIDS, AIDS, 10(1), 1996, pp. 77-80
CONSEQUENCES FOR THE MANAGEMENT OF CYTOMEGALOVIRUS
Authors: KATLAMA C
Citation: C. Katlama, CONSEQUENCES FOR THE MANAGEMENT OF CYTOMEGALOVIRUS, AIDS, 10, 1996, pp. 43-46
EPIDEMIOLOGY OF CRYPTOSPORIDIOSIS AMONG EUROPEAN AIDS PATIENTS
Authors: PEDERSEN C DANNER S LAZZARIN A GLAUSER MP WEBER R KATLAMA C BARTON SE LUNDGREN JD CLUMECK N DEWIT S SOMMEREIJNS B NIELSEN JO NIELSEN T JENSEN G SKINHOJ P BENTSEN K GERSTOFT J MELBYE M RANKI A VALLE SL BERLUREAU P DIETRICH M SCHWANDER S GOEBEL FD KOSMIDIS J STERGIOU G GOUZIA T PAPADOPOULOS A BANHEGYI D MULCAHY F YUST I BENISHAI Z BENTWICH Z SACKS T MAAYAN S VELLA S CHIESI A ANCARANI F SCALISE G BERTAGGIA A FRANCAVILLA E CALONGHI G EMILIA R CARGNEL A ARLOTTI M CIAMMARUGHI R RIMINI I COLOMBA A DELALLA F FASSIO P FERLINI A FIACCADORI F PASETTI G GIANNELLI F GRILLONE W MONFORTE AD MIGNANI E ANDREA S NUNNARI A ORTONA L PANICHI G PAULUZZI S PIERSANTELLI N RANIERI S RICCIARDIELLO P ROSCIOLI B SORANZO M HEMMER R REISS P ANTUNES F GONZALEZLAHOZ J POLO R CLOTET B GATELL J BUIRA E MIRO J PEHRSON P LUTHY R LEDERGERBER B OLSSON C GLAUSER M HIRSCHEL B JOHNSON A HAWKES S PHILLIPS A BARTON S MORCINEK J PINCHING A COLEMAN D GJORUP I NIEPORT C TEGLBJAERG L THORNVAL A
Citation: C. Pedersen et al., EPIDEMIOLOGY OF CRYPTOSPORIDIOSIS AMONG EUROPEAN AIDS PATIENTS, Genitourinary medicine, 72(2), 1996, pp. 128-131
SUMMARY OF THE INTERNATIONAL CONSENSUS SYMPOSIUM ON ADVANCES IN THE DIAGNOSIS, TREATMENT AND PROPHYLAXIS OF CYTOMEGALOVIRUS-INFECTION
Authors: VANDERMEER JTM DREW WL BOWDEN RA GALASSO GJ GRIFFITHS PD JABS DA KATLAMA C SPECTOR SA WHITLEY RJ
Citation: Jtm. Vandermeer et al., SUMMARY OF THE INTERNATIONAL CONSENSUS SYMPOSIUM ON ADVANCES IN THE DIAGNOSIS, TREATMENT AND PROPHYLAXIS OF CYTOMEGALOVIRUS-INFECTION, Antiviral research, 32(3), 1996, pp. 119-140
SAFETY AND EFFICACY OF LAMIVUDINE-ZIDOVUDINE COMBINATION THERAPY IN ANTIRETROVIRAL-NAIVE PATIENTS - A RANDOMIZED CONTROLLED COMPARISON WITHZIDOVUDINE MONOTHERAPY
Authors: KATLAMA C INGRAND D LOVEDAY C CLUMECK N MALLOLAS J STASZEWSKI S JOHNSON M HILL AM PEARCE G MCDADE H
Citation: C. Katlama et al., SAFETY AND EFFICACY OF LAMIVUDINE-ZIDOVUDINE COMBINATION THERAPY IN ANTIRETROVIRAL-NAIVE PATIENTS - A RANDOMIZED CONTROLLED COMPARISON WITHZIDOVUDINE MONOTHERAPY, JAMA, the journal of the American Medical Association, 276(2), 1996, pp. 118-125
EFFECT OF TRIMETHOPRIM ON LAMIVUDINE BIOAVAILABILITY
Authors: KATLAMA C
Citation: C. Katlama, EFFECT OF TRIMETHOPRIM ON LAMIVUDINE BIOAVAILABILITY, JAMA, the journal of the American Medical Association, 276(14), 1996, pp. 1140-1140
DYNAMICS OF VIRAL VARIANTS IN HIV-I NEF AND SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN-VIVO
Authors: HAAS G PLIKAT U DEBRE P LUCCHIARI M KATLAMA C DUDOIT Y BONDUELLE O BAUER M IHLENFELDT HG JUNG G MAIER B MEYERHANS A AUTRAN B
Citation: G. Haas et al., DYNAMICS OF VIRAL VARIANTS IN HIV-I NEF AND SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN-VIVO, The Journal of immunology, 157(9), 1996, pp. 4212-4221
HISTOLOGICAL PREDICTIVE FACTORS OF CLINICAL-RESPONSE TO THERAPY OF CMV GASTROINTESTINAL-TRACT (CIT) INFECTION IN AIDS
Authors: GANDOSSI C BENHAMOU Y KATLAMA C HOANG C POYNARD T OPOLON P
Citation: C. Gandossi et al., HISTOLOGICAL PREDICTIVE FACTORS OF CLINICAL-RESPONSE TO THERAPY OF CMV GASTROINTESTINAL-TRACT (CIT) INFECTION IN AIDS, Gastroenterology, 110(4), 1996, pp. 913-913
EFFECTS OF LAMIVUDINE ON REPLICATION OF HEPATITIS-B VIRUS IN HIV-INFECTED MEN
Authors: BENHAMOU Y KATLAMA C LUNEL F COUTELLIER A DOHIN E HAMM N TUBIANA R HERSON S POYNARD T OPOLON P
Citation: Y. Benhamou et al., EFFECTS OF LAMIVUDINE ON REPLICATION OF HEPATITIS-B VIRUS IN HIV-INFECTED MEN, Annals of internal medicine, 125(9), 1996, pp. 705
RISK-FACTORS FOR CEREBRAL TOXOPLASMOSIS I N HIV-INFECTED PATIENTS - DEFINING INDICATIONS FOR PRIMARY PROPHYLAXIS
Authors: LEPORT C AMBROISETHOMAS P BAZIN C CHENE G DEROUIN F KATLAMA C MAYAUD C PELLOUX H RAFFI F VILDE JL
Citation: C. Leport et al., RISK-FACTORS FOR CEREBRAL TOXOPLASMOSIS I N HIV-INFECTED PATIENTS - DEFINING INDICATIONS FOR PRIMARY PROPHYLAXIS, Annales de medecine interne, 147(5), 1996, pp. 331-332
THERAPEUTIC STRATEGIES FOR HIV-INFECTION, ITS LIMITATIONS AND COMPLICATIONS
Authors: FROTTIER J KATLAMA C
Citation: J. Frottier et C. Katlama, THERAPEUTIC STRATEGIES FOR HIV-INFECTION, ITS LIMITATIONS AND COMPLICATIONS, Bulletin de l'Academie nationale de medecine, 180(5), 1996, pp. 1053-1078
ADVERSE CUTANEOUS REACTIONS TO PYRIMETHAMINE SULFADIAZINE AND PYRIMETHAMINE CLINDAMYCIN IN PATIENTS WITH AIDS AND TOXOPLASMIC ENCEPHALITIS
Authors: CAUMES E BOCQUET H GUERMONPREZ G ROGEAUX O BRICAIRE F KATLAMA C GENTILINI M
Citation: E. Caumes et al., ADVERSE CUTANEOUS REACTIONS TO PYRIMETHAMINE SULFADIAZINE AND PYRIMETHAMINE CLINDAMYCIN IN PATIENTS WITH AIDS AND TOXOPLASMIC ENCEPHALITIS, Clinical infectious diseases, 21(3), 1995, pp. 656-658
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>